Share on StockTwits

ICU Medical, (NASDAQ:ICUI) shares traded up 7.4% during trading on Tuesday following a better than expected earnings announcement, Analyst Ratings reports. The company traded as high as $63.89 and last traded at $62.19, with a volume of 265,315 shares. The stock had previously closed at $57.89.

The company reported $0.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.34 by $0.04. The company had revenue of $78.70 million for the quarter, compared to the consensus estimate of $74.13 million. During the same quarter in the previous year, the company posted $0.48 earnings per share. The company’s revenue for the quarter was up .1% on a year-over-year basis.

Separately, analysts at Raymond James upgraded shares of ICU Medical, from a “market perform” rating to an “outperform” rating in a research note on Tuesday. They now have a $67.00 price target on the stock. They noted that the move was a valuation call.

In other ICU Medical, news, Director George A. Lopez sold 12,750 shares of ICU Medical, stock on the open market in a transaction dated Monday, August 11th. The shares were sold at an average price of $57.85, for a total transaction of $737,587.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

The stock’s 50-day moving average is $59.7 and its 200-day moving average is $59.73. The company has a market cap of $953.3 million and a price-to-earnings ratio of 23.17.

ICU Medical, Inc is engaged in the development, manufacture and sale of medical devices used in infusion therapy, oncology and critical care applications.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.